English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCardiologists and cardiac and vascular surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews throughout February to discuss heart-related topics, including the latest advances in research and patient care.
Tag: Raj Makkar
NEJM: Study Supports Minimally Invasive Procedure for Aortic Stenosis
Patients with a dysfunctional aortic heart valve who received a new, prosthetic valve through a minimally invasive procedure had similar outcomes at five years as those who underwent open-heart surgery, a new study shows.
Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
Study: Transcatheter Mitral Valve Repair Safe, Successful
Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.
ACC Scientific Session 2023 to Feature Smidt Heart Institute Experts
Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart surgery provider, will present innovative research findings and lead discussions on the latest high-impact medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo March 4-6 in New Orleans.
Smidt Heart Institute at 5: Breakthroughs in Research, Patient Care
Marking the five-year anniversary of the $50 million gift that named the Smidt Heart Institute, Cedars Sinai is highlighting major research breakthroughs and clinical innovations pioneered by one of the nation’s leading destinations for cardiac care.
Smidt Heart Institute Experts to Present the Latest in Heart Research, Patient Care
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
#YearofCOVID: Retooling Research to Fight a Pandemic
Susan Cheng, MD, MPH, MMSc, recalls hearing the first reports of a mysterious illness in China early last year and thinking: “This is going to be important.”
Two Clinical Trials, Two Heart Valves
Lisa Stewart doesn’t dwell on the fact that she might be the first in the nation to undergo both mitral and tricuspid valve replacement procedures. She’s too busy counting her blessings.
European Heart Journal: Cell Infusions Benefit Heart Patients
Three years after the ALLSTAR clinical trial ended prematurely, the study’s data shows that treatments of cardiosphere-derived cells — the same cells used as an experimental therapy tested in COVID-19 patients — demonstrated unexpected promise in heart attack survivors. Downloadable video available.
EMBARGOED COVID-19 RESEARCH: Patients Improve After Heart Cell Therapy
Four of six critically ill COVID-19 (coronavirus) patients significantly improved after receiving an experimental therapeutic designed to reduce inflammation, a major cause of death from this disease, according to a case series published by Cedars-Sinai and Capricor Therapeutics. The four patients got well enough to be discharged from the hospital.
NEJM: Transcatheter Aortic Valve Replacement Shows Similar Safety Outcomes as Open-Heart Surgery
A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that patients who underwent a minimally invasive transcatheter aortic-valve replacement (TAVR), had similar key 5-year clinical outcomes of death and stroke as patients who had traditional open-heart surgery to replace the valve. The study appears on the New England Journal of Medicine site.